4See Ventures is a venture capital firm based in Geneva, Switzerland, founded in 2019. It guides family offices and private professional investors in direct venture capital investments, primarily focusing on healthcare, biotech, medtech, technology, sustainability, and climate tech ventures.
Key people at 4See Ventures.
Key people at 4See Ventures.
4See Ventures is a Swiss venture capital firm that invests primarily in early-stage startups within healthcare, biotech, medtech, digital health, fintech, climate tech, and sustainability sectors, mainly focusing on Swiss companies. Their mission centers on partnering with visionary entrepreneurs who aim to disrupt markets and create positive societal impact, while guiding family offices and private investors in direct venture capital investments. The firm emphasizes transparency, trust, and collaboration, offering investors direct access to entrepreneurs and regular updates, fostering a close-knit ecosystem that supports innovation and impact-driven growth[1][2][3][4][5].
Founded by Daniel Bertholet, 4See Ventures was established with the vision of enabling family offices and professional investors to engage directly in venture capital, while backing entrepreneurs with bold visions and executable plans. The firm’s name reflects its philosophy of "foreseeing" market trends and anticipating future developments to make informed investment decisions. Over time, 4See Ventures has evolved to focus strongly on climate tech, sustainability, and healthcare, sectors where it believes transformative change is possible and necessary[2][4].
4See Ventures rides the growing global trend toward sustainability, climate action, and healthcare innovation, sectors driven by urgent societal needs and regulatory momentum. The firm’s timing aligns with increasing investor interest in impact-driven ventures and the Swiss ecosystem’s strength in biotech and climate tech innovation. By supporting startups that combine audacity with clear vision and execution, 4See Ventures influences the broader ecosystem by accelerating the development of game-changing technologies and sustainable business models[4].
Looking ahead, 4See Ventures is poised to deepen its focus on climate tech and sustainability, sectors expected to grow rapidly due to global environmental challenges and policy support. Its commitment to transparency and co-investment will likely continue to attract family offices seeking direct VC exposure with meaningful impact. As the firm scales its portfolio, it may expand beyond Switzerland, leveraging its foresight-driven investment philosophy to identify and back entrepreneurs shaping the future of healthcare and sustainability worldwide[2][4]. This positions 4See Ventures as a key player in fostering innovation that not only delivers financial returns but also drives positive societal change.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2021 | Standard Bariatrics | $35.0M Series B | — | New Leaf Venture Partners, U.S. Venture Partners |
| May 1, 2012 | Mitralign | $35.0M Series D | — | Forbion |
| Aug 1, 2007 | ReShape Lifesciences | $3.0M Series A | — | New Leaf Venture Partners, Casey Tansey |
